Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric patients with refractory systemic lupus erythematosus (SLE). The gene ...

Cell Therapy Held Larger Share in Cell and Gene Therapy Market in 2023, full analysis by Product, Application, Source, Manufacturing, and Geography. NEW YORK, Oct. 30, 2024 /PRNewswire ...

Beyond gene therapy, another issue of much debate relates to the use of stem cells. These cells can be divided into two broad classes: embryonic and adult. Both classes are currently being ...

Lentiviral self-inactivating vectors are the retroviral vectors with the greatest potential for gene therapy Nondividing cells can be transduced by lentiviral vectors. They possess a low ...

Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...

Gene therapy is a revolutionary approach to treating genetic disorders by introducing functional genes into cells to replace or correct defective genes. It involves the use of genetic material, such ...

Xcellbio developed the AVATAR platform for cell and gene therapy R&D with the AVATAR Odyssey system designed for small-scale research and process development needs. Its latest platform ...

In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...

MaxCyte, Inc., a leading, cell-engineering focused company providing ... presaging a new era in personalized medicine and gene therapy. In this interview, News-Medical talks to Mr. Byrne about ...

The 4 p.m. panel, "Science Slam: Neurological Diseases," will focus on biomarkers and endpoints development for neurodegenerative indications in the cell and gene therapy space, and provide an ...

Lentiviral self-inactivating vectors are the retroviral vectors with the greatest potential for gene therapy Nondividing cells can be transduced by lentiviral vectors. They possess a low ...